BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
목요일, 9월 24

Definium Therapeutics Inc

DFTXNASDAQ
Trade with Public
Trade with Public
$37.30
-0.35-0.94%
마지막 업데이트: Sep 24, 9:47 AM
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

Definium Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Definium Therapeutics (DFTX).

Price Target Range — 3 Quarters

Analyst Consensus — 15 Analysts

15Buy
Consensus RatingBuy# Analysts15Avg. Consensus PT$64Upside to Avg. PT+70.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →
DateFirmAnalystActionRating ChangePrice Target
Sep 15, 2026Canaccord GenuitySumant KulkarniPT RaiseBuy$64→$78
Sep 15, 2026Baird Christopher ChenPT RaiseOutperform$75→$79
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Canaccord Genuity Maintains Buy on Definium Therapeutics, Raises Price Target to $78

Canaccord Genuity analyst Sumant Kulkarni maintains Definium Therapeutics (NASDAQ:DFTX) with a Buy and raises the price target from $64 to $78.
Benzinga Newsdesk

PRO
Baird Maintains Outperform on Definium Therapeutics, Raises Price Target to $79

Baird analyst Christopher Chen maintains Definium Therapeutics (NASDAQ:DFTX) with a Outperform and raises the price target from $75 to $79.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Definium Therapeutics, Maintains $70 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Definium Therapeutics (NASDAQ:DFTX) with a Buy and maintains $70 price target.
Benzinga Newsdesk

PRO
Needham Reiterates Buy on Definium Therapeutics, Maintains $66 Price Target

Needham analyst Ami Fadia reiterates Definium Therapeutics (NASDAQ:DFTX) with a Buy and maintains $66 price target.
Benzinga Newsdesk

PRO
RBC Capital Reiterates Outperform on Definium Therapeutics, Maintains $66 Price Target

RBC Capital analyst Brian Abrahams reiterates Definium Therapeutics (NASDAQ:DFTX) with a Outperform and maintains $66 price target.
Benzinga Newsdesk

This Definium Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top analysts changed outlook on top names. See analyst ratings page for all changes.
Avi Kapoor

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved